Allergy drug approved for severe chronic rhinosinusitis with nasal polyps
News
GSK’s anti-BCMA drug Blenrep wins US approval
First anti-BCMA therapy to be approved anywhere in the world
Second COVID-19 peak in the UK can be avoided with testing and tracing, study finds
Study co-led by UCL and the London School of Hygiene & Tropical Medicine
AZ’s Fasenra study confirms robust efficacy in eosinophilic asthma
Drug reduced annual rate of asthma exacerbations by 49%
UCB’s Cimzia bags EU label extension
Drug is first biologic in Europe to be approved with a dose reduction label for axSpA patients
NICE updates guidance on chronic pain treatments
Draft guidance says some commonly used drug treatments should be avoided
Novavax’s COVID-19 vaccine produces immune response in early study
Vaccine was generally well-tolerated with only a few mild side-effects reported
Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial
Company expect to file regulatory submissions in 2021
Pharma’s reputation has climbed during COVID-19 pandemic, study finds
Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings
AstraZeneca forges licensing agreement with Redx Pharma
AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset
NHS adapts to pandemic with ‘COVID-friendly’ cancer treatments
Health service extends access to at-home treatments to reduce patients’ risk of contracting coronavirus
Janssen’s depression nasal spray Spravato bags new FDA approval
Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour
Oxford Biomedica and Beam Therapeutics sign CAR-T deal
Agreement will utilise Oxford Biomedica’s LentiVector platform
Roche’s tumour-agnostic therapy Rozlytrek approved in EU
Therapy has been approved to treat advanced NTRK fusion-positive solid tumours
UK increases COVID-19 vaccine manufacturing capacity
New deal with Wockhardt boosts capacity at the crucial ‘fill and finish’ stage
